Company intelligence / Profile preview

Vestagen Protective Technologies

Orlando, Florida, United States

Ownership: Private
Development stage: Other

Overview

VESTEX Active Barrier healthcare uniforms received FDA 510(k) clearance as a Class II medical device in May 2018, becoming the first daily-wear scrubs to receive this designation. Clinical trials conducted at Virginia Commonwealth University demonstrated that VESTEX apparel reduces MRSA retention on healthcare worker clothing compared to conventional scrubs, with effectiveness lasting up to 12 hours.[4] The fabric demonstrates fluid repellency to blood, urine, sputum, gastric fluid, and other hazardous materials within 15 minutes of exposure.[4]

Therapeutic areas: Infectious Diseases
Modalities: Medical textile/Device
Industry: Consumable Medical Devices

Partnerships

Baptist Health (Jacksonville)Northwell Health (New York)Mercy Health (Cincinnati)Standard TextileAmerican Hospital Association (endorsement)

Beyond the preview

Go deeper on Vestagen Protective Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vestagen Protective Technologies.

Explore the full profile